Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRAIL: Gabapentin for HIV Viral Load Suppression in Heavy Drinkers
NCT05443555Phase 2Active, not recruiting
- Sponsor
- Boston Medical Center
- Start
- Nov 2023
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in alcohol use disorder (AUD), sponsored by Boston Medical Center. Started Nov 2023; status: active, not recruiting.
02
Drugs
gabapentin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05443555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05443555.